The Hemochromatosis Market Is Trending Towards Cell-Based Therapies The hemochromatosis market comprises products that are used to treat iron overload disorder known as hemochromatosis. These products involve phlebotomy, chelating agents, and other medications that help manage excess iron levels in the body. The condition commonly occurs due to a genetic mutation that inhibits the body's ability to regulate iron absorption from food. Left untreated, hemochromatosis can damage vital organs like the liver, heart, and pancreas and even cause cancer or liver disease. The global hemochromatosis market is estimated to be valued at US$ 1.60 Bn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2031. Get More Insights On Hemochromatosis Market https://hallbook.com.br/blogs/366195/The-Hemochromatosis-Market-Is-Trending-Towards-Cell-Based-Therapies